Citigroup’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-12
| Closed | -$32 | – | 6525 |
|
|
2025
Q3 | $32 | Sell |
12
-2,931
| -100% | -$8.68K | ﹤0.01% | 5874 |
|
|
2025
Q2 | $8.74K | Sell |
2,943
-10,881
| -79% | -$31.6K | ﹤0.01% | 5210 |
|
|
2025
Q1 | $44.8K | Sell |
13,824
-1,545
| -10% | -$5.33K | ﹤0.01% | 4902 |
|
|
2024
Q4 | $60.7K | Buy |
15,369
+852
| +6% | +$5.81K | ﹤0.01% | 5037 |
|
|
2024
Q3 | $112K | Buy |
14,517
+10,363
| +249% | +$68.1K | ﹤0.01% | 4714 |
|
|
2024
Q2 | $21.4K | Sell |
4,154
-32,598
| -89% | -$251K | ﹤0.01% | 4983 |
|
|
2024
Q1 | $299K | Buy |
36,752
+22,013
| +149% | +$126K | ﹤0.01% | 3838 |
|
|
2023
Q4 | $59K | Buy |
14,739
+14,337
| +3,566% | +$57.1K | ﹤0.01% | 4444 |
|
|
2023
Q3 | $1.66K | Buy |
+402
| New | +$2.01K | ﹤0.01% | 5012 |
|
|
2022
Q3 | – | Sell |
-151
| Closed | -$1K | – | 6374 |
|
|
2022
Q2 | $1K | Sell |
151
-1,137
| -88% | -$7.65K | ﹤0.01% | 6108 |
|
|
2022
Q1 | $11K | Sell |
1,288
-2,928
| -69% | -$29.4K | ﹤0.01% | 5491 |
|
|
2021
Q4 | $47K | Buy |
4,216
+560
| +15% | +$7.29K | ﹤0.01% | 5102 |
|
|
2021
Q3 | $47K | Buy |
3,656
+775
| +27% | +$12.3K | ﹤0.01% | 4769 |
|
|
2021
Q2 | $48K | Buy |
2,881
+1,211
| +73% | +$20.5K | ﹤0.01% | 4851 |
|
|
2021
Q1 | $29K | Sell |
1,670
-2,172
| -57% | -$40.5K | ﹤0.01% | 5036 |
|
|
2020
Q4 | $60K | Buy |
3,842
+1,301
| +51% | +$24K | ﹤0.01% | 5917 |
|
|
2020
Q3 | $49K | Sell |
2,541
-3,691
| -59% | -$63.7K | ﹤0.01% | 5611 |
|
|
2020
Q2 | $85K | Sell |
6,232
-125
| -2% | -$1.76K | ﹤0.01% | 5716 |
|
|
2020
Q1 | $68K | Sell |
6,357
-620
| -9% | -$10.1K | ﹤0.01% | 5690 |
|
|
2019
Q4 | $130K | Buy |
6,977
+6,036
| +641% | +$77.7K | ﹤0.01% | 5526 |
|
|
2019
Q3 | $10K | Sell |
941
-3,740
| -80% | -$30.5K | ﹤0.01% | 7087 |
|
|
2019
Q2 | $35K | Sell |
4,681
-19,368
| -81% | -$168K | ﹤0.01% | 6766 |
|
|
2019
Q1 | $265K | Buy |
+24,049
| New | +$195K | ﹤0.01% | 4827 |
|
|
2018
Q2 | – | Sell |
-2,516
| Closed | -$14K | – | 7755 |
|
|
2018
Q1 | $14K | Buy |
2,516
+525
| +26% | +$2.42K | ﹤0.01% | 6922 |
|
|
2017
Q4 | $8K | Buy |
1,991
+650
| +48% | +$2.74K | ﹤0.01% | 7121 |
|
|
2017
Q3 | $6K | Buy |
1,341
+1,212
| +940% | +$5.72K | ﹤0.01% | 6826 |
|
|
2017
Q2 | $1K | Buy |
129
+90
| +231% | +$862 | ﹤0.01% | 7216 |
|
|
2017
Q1 | $1K | Sell |
39
-19,672
| -100% | -$258K | ﹤0.01% | 7113 |
|
|
2016
Q4 | $199K | Buy |
19,711
+18,508
| +1,538% | +$246K | ﹤0.01% | 5278 |
|
|
2016
Q3 | $16K | Sell |
1,203
-4,534
| -79% | -$66.5K | ﹤0.01% | 6331 |
|
|
2016
Q2 | $120K | Sell |
5,737
-1,681
| -23% | -$24.3K | ﹤0.01% | 4934 |
|
|
2016
Q1 | $70K | Buy |
7,418
+1,734
| +31% | +$14.4K | ﹤0.01% | 5915 |
|
|
2015
Q4 | $62K | Buy |
5,684
+5,683
| +568,300% | +$72.6K | ﹤0.01% | 5765 |
|
|
2015
Q3 | $0 | Sell |
1
-53
| -98% | -$928 | ﹤0.01% | 7756 |
|
|
2015
Q2 | $1K | Buy |
+54
| New | +$1.12K | ﹤0.01% | 7346 |
|
Other funds holding XBIT
RC
BCM
Citigroup's XBIT Position: Q4 2025 in Review
Citigroup sold out of XBiotech (XBIT) in Q4 2025, closing a stake of 12 shares — an estimated $32 sold.
Citigroup first reported a position in XBIT in Q2 2015 and held it in 35 quarters. The position peaked at $299K in Q1 2024. 41 funds tracked by Wall St. Rank hold XBIT as of Q4 2025.
- Citigroup reported no remaining XBiotech position as of Q4 2025 after selling out during the quarter.
- Citigroup sold 12 XBiotech shares in Q4 2025, an estimated $32.
- Citigroup first reported a position in XBiotech in Q2 2015 and held it in 35 quarters.
- Citigroup's XBiotech position peaked at $299K in Q1 2024.
- 41 funds tracked by Wall St. Rank held XBiotech as of Q4 2025.
Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.